Literature DB >> 17626118

Functional imaging of cancer with emphasis on molecular techniques.

Drew A Torigian1, Steve S Huang, Mohamed Houseni, Abass Alavi.   

Abstract

A multitude of noninvasive, quantitative, functional imaging techniques are currently in use to study tumor physiology, to probe tumor molecular processes, and to study tumor molecules and metabolites in vitro and in vivo using computed tomography (CT), magnetic resonance imaging (MRI), ultrasonography (US), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and optical imaging (OI). Such techniques can be used in conjunction with structural imaging techniques to detect, diagnose, characterize, or monitor tumors before and after therapeutic intervention. These can also be used to study tumor gene expression, to track cells and therapeutic drugs, to optimize individualized treatment planning for patients with tumors, and to foster new oncologic drug development. In this article, we review the rich variety of functional imaging techniques that are available for these purposes, which are becoming increasingly important for optimal individualized patient treatment in this day and age of "personalized medicine."

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626118     DOI: 10.3322/canjclin.57.4.206

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  29 in total

1.  The role of magnetic resonance imaging in oncology.

Authors:  Concepción González Hernando; Laura Esteban; Teresa Cañas; Enrique Van den Brule; Miguel Pastrana
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 2.  In vivo imaging in cancer.

Authors:  John Condeelis; Ralph Weissleder
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-22       Impact factor: 10.005

Review 3.  In vivo imaging of molecular targets and their function in endocrinology.

Authors:  Joanna E Burdette
Journal:  J Mol Endocrinol       Date:  2008-06       Impact factor: 5.098

Review 4.  Evolving role of FDG PET imaging in assessing joint disorders: a systematic review.

Authors:  Kathleen Carey; Babak Saboury; Sandip Basu; Alex Brothers; Alexis Ogdie; Tom Werner; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-14       Impact factor: 9.236

Review 5.  Predicting outcomes in radiation oncology--multifactorial decision support systems.

Authors:  Philippe Lambin; Ruud G P M van Stiphout; Maud H W Starmans; Emmanuel Rios-Velazquez; Georgi Nalbantov; Hugo J W L Aerts; Erik Roelofs; Wouter van Elmpt; Paul C Boutros; Pierluigi Granone; Vincenzo Valentini; Adrian C Begg; Dirk De Ruysscher; Andre Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

Review 6.  Non-invasive molecular imaging for preclinical cancer therapeutic development.

Authors:  A C O'Farrell; S D Shnyder; G Marston; P L Coletta; J H Gill
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

7.  Dual-Modality Optical/PET Imaging of PARP1 in Glioblastoma.

Authors:  Giuseppe Carlucci; Brandon Carney; Christian Brand; Susanne Kossatz; Christopher P Irwin; Sean D Carlin; Edmund J Keliher; Wolfgang Weber; Thomas Reiner
Journal:  Mol Imaging Biol       Date:  2015-12       Impact factor: 3.488

8.  Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child.

Authors:  R Demlova; K Melicharkova; Z Rehak; L Kren; H Oslejskova; J Sterba
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

Review 9.  Use of radionuclides in cancer research and treatment.

Authors:  M T Macías
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

10.  Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors.

Authors:  Lillian L Siu; Roberto Pili; Ignacio Duran; Wells A Messersmith; Eric X Chen; Rana Sullivan; Martha MacLean; Serina King; Shirley Brown; Gregory K Reid; Zuomei Li; Ann M Kalita; Eric J Laille; Jeffrey M Besterman; Robert E Martell; Michael A Carducci
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.